Dr. Herman Weiss

PMOS Is a Life Sentence — Not a Fertility Problem

The Substack post your 46-year-old patient never got from her last doctor.

Dr. Herman Weiss's avatar
Dr. Herman Weiss
Jun 04, 2026
∙ Paid

She Was Told She Was “Past It.” She Wasn’t.

She sat across from me, 46 years old, sharp, self-aware, and visibly frustrated. She’d spent decades understanding her body — the insulin swings, the hair changes, the way her energy crashed in a predictable rhythm she’d learned to manage through sheer discipline and trial and error. She’d built a life around this condition.

And then a physician told her: “You don’t need to worry about PCOS anymore. You’re past your childbearing years.”

I put my hand on my forehead.

Not out of frustration with her. Out of grief for how many women have heard some version of that sentence. How many have been handed a permission slip to stop paying attention to something that never stopped mattering.

PCOS — now being reclassified in the medical literature as PMOS: Polyendocrine Metabolic Ovarian Syndrome — was never a fertility condition wearing a hormonal costume. It was always a whole-life metabolic disorder that happened to show up first in the reproductive years because that’s when the symptoms were loud enough to get a diagnosis.

The ovaries were just the first organ brave enough to raise its hand.


What the Reclassification of PCOS to PMOS Actually Means

The May 2026 Lancet reclassification to PMOS is not a bureaucratic rename. It is a correction of a 30-year clinical mistake — the mistake of framing this condition through the narrow lens of reproduction.

PMOS is a polyendocrine disorder. That means it doesn’t live in one system. It spans the ovaries, the adrenal axis, the pancreas, the gut, the liver, and the brain. The metabolic dysfunction at its core — insulin resistance, chronic low-grade inflammation, dysregulated androgens — does not retire when the period stops.

If anything, the perimenopausal transition amplifies it.

Here is what clinicians should have been saying for decades:

“Your diagnosis today is a metabolic roadmap for the rest of your life. The choices you make in your 20s, 30s, and 40s will determine what your 50s, 60s, and 70s look like.”

Most women never heard that sentence. This post is for them.


The Early Warning Signs No One Connects to PMOS

The tragedy of PMOS is that its earliest signals are almost universally dismissed, minimized, or attributed to lifestyle — as if lifestyle and biology exist in separate rooms.

Markers to watch for, beginning in adolescence:

  • Irregular cycles from the start — not just “normal teen irregularity,” but persistent, unpredictable cycles beyond 2 years post-menarche

  • Acanthosis nigricans — darkened, velvety skin at the neck, underarms, or groin — one of the earliest visible signs of insulin resistance

  • Acne that doesn’t respond to standard treatment, particularly along the jawline and chin

  • Elevated fasting insulin (not just fasting glucose — insulin rises first, often years before glucose moves)

  • Elevated triglycerides with low HDL — the classic dyslipidemia pattern of insulin resistance, visible in teenage bloodwork

  • Unexplained fatigue, especially post-carbohydrate

  • Difficulty with weight regulation disproportionate to caloric intake

  • Family history of T2DM, early cardiovascular disease, or metabolic syndrome — PMOS is heritable; a mother or aunt with “bad blood sugar” may be the most important clue in the room

  • Elevated LH:FSH ratio on early cycle bloodwork

  • Androgens trending high — even within “normal” lab ranges, trajectory matters

None of these in isolation makes a diagnosis. But a clinician trained to see PMOS as a metabolic syndrome will recognize the constellation — and act early, when action changes outcomes most.


Why the Perimenopausal Years Are the Danger Zone

Here is the biology that my patient’s prior physician missed entirely:

Estrogen is metabolically protective. It improves insulin sensitivity. It modulates inflammation. It supports cardiovascular endothelium.

As estrogen declines through perimenopause, women with underlying PMOS lose that protection on top of the metabolic dysfunction they already carried. The result is a compounding risk that standard screening frameworks — designed for average-risk women — systematically underestimate.

Women with PMOS entering perimenopause face elevated risk for:

  • Type 2 diabetes (2–4x higher lifetime risk)

  • Cardiovascular disease — earlier onset, more aggressive progression

  • Non-alcoholic fatty liver disease

  • Sleep apnea (vastly underdiagnosed in women)

  • Endometrial hyperplasia due to unopposed estrogen from anovulation

  • Cognitive changes — emerging research links insulin resistance to accelerated neurological aging

This is not a list to frighten you. It is a list to orient you. Because every single item on it is modifiable — if you start early enough, and if you have a clinical team that understands what they’re dealing with.


The Diagnosis Should Have Been a Starting Line, Not a Label

When I see a 19-year-old with PMOS, I do not think: fertility patient.

I think: here is a woman who, if we intervene thoughtfully right now, may never develop T2DM. May never have a cardiac event at 58. May never sit across from a physician at 70 and hear that her “metabolic syndrome” came out of nowhere.

The PMOS diagnosis is one of the most powerful preventive medicine opportunities in all of women’s health. It is a biological signal, years or decades before damage accumulates, that the metabolic machinery needs support.

A 23-year-old diagnosed with PMOS who understands what she is managing — and has the clinical guidance to act on it — has a fundamentally different trajectory than one who is told to “lose weight, take the pill, and come back when you want to get pregnant.”

That difference is what we build at ProvationLife. That difference is the conversation I’m trying to create.


What follows is the clinical action framework I walk through with my own patients — the lifestyle interventions with the strongest evidence base, the supplement and nutritional strategies that actually move the needle, and the specific lab panels I recommend by life stage. This is the roadmap your PMOS diagnosis should have come with.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

The PMOS Life-Stage Intervention Framework

(For members — the evidence-based protocol, by decade)

User's avatar

Continue reading this post for free, courtesy of Dr. Herman Weiss.

Or purchase a paid subscription.
© 2026 Dr. Herman Weiss · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture